Kidney disease and renal function
Clinical research activity includes autosomal dominant polycystic kidney disease, with attention to preservation of estimated glomerular filtration rate and slowing progression of chronic kidney disease in adults.
- Autosomal dominant polycystic kidney disease
- Renal function decline
- Chronic kidney disease
Work in this area reflects interest in comparative therapeutic strategies used to support long-term kidney health and disease management.
Gastroenterology and eosinophilic esophagitis
Research also covers eosinophilic esophagitis in children and adolescents, focusing on inflammatory disease affecting the esophagus and symptom control.
- Eosinophilic esophagitis
- Pediatric gastroenterology
- Esophageal inflammation
The sponsor’s portfolio includes interest in formulations used for mucosal treatment in pediatric digestive disorders.
Metabolic and repurposed therapy interests
The funded studies include evaluation of metformin within a kidney disease setting, indicating interest in metabolic agents and their potential role beyond traditional indications.
- Metformin
- Therapeutic repurposing
- Renoprotective treatment
This area links metabolic pharmacology with renal care and comparative treatment selection.
Inflammatory and topical corticosteroid therapies
Another focus is the use of budesonide in a viscous oral formulation for inflammatory disease of the upper gastrointestinal tract, with relevance to local anti-inflammatory treatment.
- Budesonide
- Topical corticosteroid therapy
- Swallowing and esophageal delivery
This highlights interest in disease-specific formulations for pediatric esophageal disorders.
